Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Cholecystokinin Receptor Blockade on the Tumor Microenvironment in Pancreatic Cancer

NCT05827055 is registered in ClinicalTrials.gov with Georgetown University as lead sponsor.

NCT NCT05827055
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05827055 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Cholecystokinin Receptor Blockade on the Tumor Microenvironment in Pancreatic Cancer
Lead sponsor
Georgetown University
Phase
Phase 2
Overall status
Active, not recruiting
Start date
January 31, 2024
Completion date
January 31, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic pancreatic cancer